Security Snapshot

Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) Institutional Ownership

CUSIP: 344174107

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

85

Shares (Excl. Options)

36.23MFull value: 36,226,920 · shares · 30 Sep 2026

Price

$3.57

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,404,301
Value change
+$4,523,138
Number of holders
85
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
59,489,510
SEC-reported price per share
$2.05
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • FHTX - Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 344174107.
  • 85 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 102 to 85 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $219.22MFull value: $219,219,389 · USD · 30 Jun 2026
    to
    $129.33MFull value: $129,334,407 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 85 institutions filings for Q3 2026.

Open SEC evidence

Security key

344174107

13F reference period

Q3 2026

13F holders

85

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
FHTX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flagship Ventures Fund V, L.P. 27% $112,194,766 20,774,885 Noubar Afeyan 09 Jan 2026
BIOTECHNOLOGY VALUE FUND L P 14% +43% $48,404,830 +$15,023,802 8,507,000 +45% BVF PARTNERS L P/IL 01 Oct 2026
FMR LLC 12% +14% $32,467,462 +$5,270,605 6,792,356 +19% FMR LLC 31 Mar 2026
Flynn James E 8.6% $24,566,920 5,139,523 Deerfield Mgmt, L.P. 31 Mar 2026
As of 30 Sep 2026, 85 institutional investors reported holding
36.23MFull value: 36,226,920 · shares · 30 Sep 2026
shares of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX). This represents 61% of the company’s total
59.49MFull value: 59,489,510 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Flagship Pioneering, LLC 21% 12,674,120 2.3% $45,246,608
BVF INC/IL 9.8% 5,842,000 0.69% $20,855,940
DEERFIELD MANAGEMENT COMPANY, L.P. 7.4% 4,394,367 0.24% $15,687,890
RAYMOND JAMES FINANCIAL INC 4.2% 2,479,621 0% $8,852,247
VANGUARD CAPITAL MANAGEMENT LLC 2.7% 1,586,219 0% $5,662,802
Euclidean Capital LLC 2.6% 1,573,761 1.7% $5,618,327
GEODE CAPITAL MANAGEMENT, LLC 1.4% 861,655 0% $3,076,895
Siren, L.L.C. 1.2% 720,720 0.06% $2,572,970
STATE STREET CORP 1.2% 692,290 0% $2,471,475
Qube Research & Technologies Ltd 0.91% 540,315 0% $1,928,925
RENAISSANCE TECHNOLOGIES LLC 0.73% 432,339 0% $1,543,450
VANGUARD PORTFOLIO MANAGEMENT LLC 0.57% 338,066 0% $1,206,896
Birchview Capital, LP 0.47% 282,307 0.58% $1,007,836
VANGUARD FIDUCIARY TRUST CO 0.46% 275,130 0% $982,214
GOLDMAN SACHS GROUP INC 0.39% 234,669 0% $837,768
PANAGORA ASSET MANAGEMENT INC 0.38% 227,091 0% $810,715
B Group, Inc. 0.34% 200,000 0.44% $714,000
Ikarian Capital, LLC 0.27% 160,000 0.11% $571,201
MACKENZIE FINANCIAL CORP 0.25% 151,354 0% $540,334
SCS Capital Management LLC 0.18% 106,980 0% $381,919
Point72 Asset Management, L.P. 0.18% 106,201 0% $379,138
DAFNA Capital Management LLC 0.15% 89,659 0.07% $320,083
Palumbo Wealth Management LLC 0.15% 88,791 0.07% $316,984
Invesco Ltd. 0.14% 83,313 0% $297,428
Trexquant Investment LP 0.13% 79,711 0% $284,568

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Headline period
Q3 2026
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 36,226,920 $129,334,407 +$4,523,138 $3.57 85
2026 Q2 44,923,154 $219,219,389 +$2,418,390 $4.88 102
2026 Q1 44,440,227 $212,433,143 +$11,728,970 $4.78 104
2025 Q4 41,875,144 $226,126,895 +$5,631,604 $5.40 93
2025 Q3 40,899,067 $199,997,332 -$252,615 $4.89 86
2025 Q2 40,966,679 $192,544,370 +$2,995,463 $4.70 79
2025 Q1 40,422,738 $147,539,082 +$554,807 $3.65 89
2024 Q4 40,250,865 $189,972,345 +$1,515,315 $4.72 86
2024 Q3 39,996,016 $372,365,052 +$3,205,361 $9.31 78
2024 Q2 39,443,565 $226,852,214 +$74,393,685 $5.75 71
2024 Q1 26,459,793 $177,447,258 +$1,618,684 $6.71 67
2023 Q4 26,194,106 $168,954,975 -$3,389,727 $6.45 59
2023 Q3 26,924,936 $134,628,591 +$778,966 $5.00 61
2023 Q2 26,763,756 $188,422,208 +$3,982,788 $7.04 59
2023 Q1 26,253,067 $162,763,500 +$937,198 $6.20 61
2022 Q4 26,093,883 $166,474,381 -$1,442,468 $6.38 63
2022 Q3 26,307,921 $225,720,907 +$12,954 $8.58 60
2022 Q2 26,276,584 $357,367,427 +$18,367,020 $13.60 55
2022 Q1 24,903,791 $379,088,288 +$4,677,182 $15.23 57
2021 Q4 24,151,188 $552,334,813 +$1,462,679 $22.87 58
2021 Q3 11,606,587 $161,634,440 +$5,200,204 $13.93 44
2021 Q2 11,234,597 $119,870,494 +$2,946,090 $10.67 36
2021 Q1 10,646,057 $139,604,845 -$678,194 $13.18 43
2020 Q4 10,612,558 $212,930,838 +$187,364,837 $20.27 45
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .